Bristol Myers to merge scientific, clinical teams under new R&D structure
BMY•Bristol Myers Squibb will combine its scientific and clinical expertise teams into an end-to-end R&D department under Chief Medical Officer Cristian Massacesi, effective January 1, 2027. Chief Research Officer Robert Plenge will leave in March 2027 after the transition.
1. R&D reorganization
Bristol Myers Squibb said it will bring its scientific and clinical expertise teams together in an end-to-end research and development department led by current Chief Medical Officer Cristian Massacesi, effective January 1, 2027. Current Chief Research Officer Robert Plenge will leave in March 2027 after the transition. CEO Christopher Boerner said the change is intended to connect scientific and clinical expertise, accelerate decision making and enhance portfolio execution.
